MDMA 2022 Medical Technology Executive Forum

Friday, September 23, 2022 – 11:00am-4:00pm ET

11:00am – 11:05am

Welcoming Remarks

  • Mark Leahey, President & CEO, MDMA

11:05am – 11:35am

Trends in MedTech Investment and Exits

  • Jonathan Norris, Managing Director, Life Science & Healthcare Practice, Silicon Valley Bank

11:35am – 12:05pm

Diversity in MedTech

12:05pm – 1:05pm
CDRH Update

  • William Maisel, Office Director, Office of Product Evaluation and Quality, CDRH Chief Medical Officer, FDA

1:05pm – 1:20pm
Break
 

1:20pm – 2:00pm
CMS Update

2:00pm – 2:30pm
Election Update

  • Josh Holmes, President, Founding Partner, Cavalry, LLC
  • Andrew Rosenberg, Partner, Thorn Run Partners

2:30pm – 3:15pm
The Future of MedTech Innovation

  • Josh Makower, Director & Co-Founder, Stanford Byers Center for Biodesign

3:15pm – 3:45pm
Update on EU MDR

  • Phil Brown, Director, Regulatory & Compliance, ABHI
  • Ed Rozynski, Sr. International Advisor, MDMA

3:45pm
Closing Remarks

  • Mark Leahey, President & CEO, MDMA